178 related articles for article (PubMed ID: 18600435)
1. IkappaBalpha promoter polymorphisms in patients with primary Sjögren's syndrome.
Ou TT; Lin CH; Lin YC; Li RN; Tsai WC; Liu HW; Yen JH
J Clin Immunol; 2008 Sep; 28(5):440-4. PubMed ID: 18600435
[TBL] [Abstract][Full Text] [Related]
2. IkBα promoter polymorphisms in patients with ankylosing spondylitis.
Hung YH; Ou TT; Lin CH; Li RN; Lin YC; Tsai WC; Liu HW; Yen JH
Rheumatol Int; 2009 Nov; 30(1):93-7. PubMed ID: 19363678
[TBL] [Abstract][Full Text] [Related]
3. IkappaBalpha promoter polymorphisms in patients with Behçet's disease.
Hung YH; Wu CC; Ou TT; Lin CH; Li RN; Lin YC; Tsai WC; Liu HW; Yen JH
Dis Markers; 2010; 28(1):55-62. PubMed ID: 20164548
[TBL] [Abstract][Full Text] [Related]
4. I kappa B alpha promoter polymorphisms in patients with systemic lupus erythematosus.
Lin CH; Wang SC; Ou TT; Li RN; Tsai WC; Liu HW; Yen JH
J Clin Immunol; 2008 May; 28(3):207-13. PubMed ID: 18071880
[TBL] [Abstract][Full Text] [Related]
5. Inhibitor IκBα promoter functional polymorphisms in patients with multiple sclerosis.
Balood M; Mesbah-Namin SA; Sanati MH; Zahednasab H; Sahraian MA; Ataei M
Mol Biol Rep; 2014 Feb; 41(2):613-6. PubMed ID: 24368589
[TBL] [Abstract][Full Text] [Related]
6. Defective feedback regulation of NF-kappaB underlies Sjogren's syndrome in mice with mutated kappaB enhancers of the IkappaBalpha promoter.
Peng B; Ling J; Lee AJ; Wang Z; Chang Z; Jin W; Kang Y; Zhang R; Shim D; Wang H; Fleming JB; Zheng H; Sun SC; Chiao PJ
Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15193-8. PubMed ID: 20696914
[TBL] [Abstract][Full Text] [Related]
7. IkappaBalpha promoter polymorphisms in patients with rheumatoid arthritis.
Lin CH; Ou TT; Wu CC; Tsai WC; Liu HW; Yen JH
Int J Immunogenet; 2007 Feb; 34(1):51-4. PubMed ID: 17284228
[TBL] [Abstract][Full Text] [Related]
8. Altered IκBα expression promotes NF-κB activation in monocytes from primary Sjögren's syndrome patients.
Lisi S; Sisto M; Lofrumento DD; D'Amore M
Pathology; 2012 Oct; 44(6):557-61. PubMed ID: 22935973
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism in the TNF-alpha gene promoter at position -1031 is associated with increased circulating levels of TNF-alpha, myeloperoxidase and nitrotyrosine in primary Sjögren's syndrome.
Cay HF; Sezer I; Dogan S; Felek R; Aslan M
Clin Exp Rheumatol; 2012; 30(6):843-9. PubMed ID: 22703762
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of the mannose binding lectin gene in patients with Sjögren's syndrome.
Wang ZY; Morinobu A; Kanagawa S; Kumagai S
Ann Rheum Dis; 2001 May; 60(5):483-6. PubMed ID: 11302870
[TBL] [Abstract][Full Text] [Related]
11. Fas gene promoter polymorphisms in primary Sjögren's syndrome.
Mullighan CG; Heatley S; Lester S; Rischmueller M; Gordon TP; Bardy PG
Ann Rheum Dis; 2004 Jan; 63(1):98-101. PubMed ID: 14672901
[TBL] [Abstract][Full Text] [Related]
12. IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C.
He Y; Zhang H; Yin J; Xie J; Tan X; Liu S; Zhang Q; Li C; Zhao J; Wang H; Cao G
Carcinogenesis; 2009 Nov; 30(11):1916-22. PubMed ID: 19797428
[TBL] [Abstract][Full Text] [Related]
13. CC chemokine receptor 5 and interleukin-1 receptor antagonist gene polymorphisms in patients with primary Sjögren's syndrome.
Petrek M; Cermáková Z; Hutyrová B; Miceková D; Drábek J; Rovensky J; Bosák V
Clin Exp Rheumatol; 2002; 20(5):701-3. PubMed ID: 12412204
[TBL] [Abstract][Full Text] [Related]
14. Association of transforming growth factor beta1 and tumor necrosis factor alpha polymorphisms with anti-SSB/La antibody secretion in patients with primary Sjögren's syndrome.
Gottenberg JE; Busson M; Loiseau P; Dourche M; Cohen-Solal J; Lepage V; Charron D; Miceli C; Sibilia J; Mariette X
Arthritis Rheum; 2004 Feb; 50(2):570-80. PubMed ID: 14872501
[TBL] [Abstract][Full Text] [Related]
15. Inhibitor IkappaBalpha promoter functional polymorphisms in patients with rheumatoid arthritis.
Li RN; Hung YH; Lin CH; Chen YH; Yen JH
J Clin Immunol; 2010 Sep; 30(5):676-80. PubMed ID: 20563630
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of the interleukin 10 gene promoter are not associated with anti-Ro autoantibodies in primary Sjögren's syndrome.
Limaye V; Lester S; Downie-Doyle S; Pile K; Bardy P; Gordon TP; Rischmueller M
J Rheumatol; 2000 Dec; 27(12):2945-6. PubMed ID: 11128696
[No Abstract] [Full Text] [Related]
17. Association of TNFSF4 polymorphisms with susceptibility to primary Sjögren's syndrome and primary biliary cirrhosis in a Chinese Han population.
Kong F; Li JX; Li P; Li YZ; Zhang FC; Zhang J
Clin Exp Rheumatol; 2013; 31(4):546-51. PubMed ID: 23622253
[TBL] [Abstract][Full Text] [Related]
18. No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome.
Gottenberg JE; Sellam J; Ittah M; Lavie F; Proust A; Zouali H; Sordet C; Sibilia J; Kimberly RP; Mariette X; Miceli-Richard C
Arthritis Res Ther; 2006; 8(1):R30. PubMed ID: 16507129
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin kappa light chain gene alleles are not associated with primary Sjögren's syndrome.
Downie-Doyle S; Lester S; Bardy P; Gordon T; Rischmueller M; Pile K
Genes Immun; 2002 Oct; 3 Suppl 1():S63-5. PubMed ID: 12215905
[TBL] [Abstract][Full Text] [Related]
20. Homozygosity for the 168His variant of the minor histocompatibility antigen HA-1 is associated with reduced risk of primary Sjögren's syndrome.
Harangi M; Kaminski WE; Fleck M; Orsó E; Zeher M; Kiss E; Szekanecz Z; Zilahi E; Marienhagen J; Aslanidis C; Paragh G; Bolstad AI; Jonsson R; Schmitz G
Eur J Immunol; 2005 Jan; 35(1):305-17. PubMed ID: 15593299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
